Government Analyst
| S.No. | Name of Government Analyst | Class of Drugs | Gazette Notification No. | Download |
| 1 | (a) Dr.J. P.Prasad | (i) Human Albumin; | S.O. 4271 (E) dated 26 November 2019 |  |
| (ii) Human Normal Immunoglobulin (Intramuscular and intravenous); | ||||
| (iii) Human Coagulation Factor VIII; | ||||
| (iv) Human Coagulation Factor IX; | ||||
| (v)Plasma Protein Fraction | ||||
| (vi)Fibrin Sealant Kit | ||||
| (vii)Anti-Inhibitor Coagulation Complex | ||||
| (b) Dr. Meena Kumari | (i) Human Albumin; | |||
| (ii) Human Normal Immunoglobulin (Intramuscular and intravenous); | ||||
| (iii) Human Coagulation Factor VIII; | ||||
| (iv) Human Coagulation Factor IX; | ||||
| (v)Plasma Protein Fraction | ||||
| (vi)Fibrin Sealant Kit | ||||
| (vii)Anti-Inhibitor Coagulation Complex | ||||
| (c)Sh. Harit Kasana | Vaccine Products - | |||
| (i)Bacillus Calmette-Guerin (BCG) vaccine | ||||
| (ii)Live Attenuated Measles vaccine | ||||
| (iii)Live Attenuated Rubella vaccine | ||||
| (iv)Cell Cultutre Rabies vaccine | ||||
| (v)Oral Polio Vaccine | ||||
| (d) Ms. Ajanta Sircar | (i)Glucose Test Strips; and | |||
| (ii)Fully automated analyser based glucose reagent | ||||
| (e) Dr. Charu. M. Kamal | Recombinants Products- | |||
| (i)Recombinant Insulin and Insulin analogues | ||||
| (ii)r-erythropoietin (EPO) | ||||
| (iii)r-Granulocyte Colony Stimulating Factor (G-CSF) | ||||
| (f) Rajesh Kumar Sharma | (i)Human Immunodeficiency Virus | |||
| (ii)Hepatitis B Surface Antigen | ||||
| (iii)Hepatitis C Virus | ||||
| (g) Ms. Madhu Erramilli | (i)Human Albumin | |||
| (ii) Human Normal Immunoglobulin (Intramuscular and intravenous); | ||||
| (iii) Human Coagulation Factor VIII; | ||||
| (iv) Human Coagulation Factor IX; | ||||
| (v)Plasma Protein Fraction | ||||
| (vi)Fibrin Sealant Kit | ||||
| (vii)Anti-Inhibitor Coagulation Complex | ||||
| (h) Ms. Kanchan Ahuja | Blood Grouping Reagents | |||
| (i) Ms. Gurminder Bindra | Recombinants Products- | |||
| (i)Recombinant Insulin and Insulin analogues | ||||
| (ii)r-erythropoietin (EPO) | ||||
| (iii)r-Granulocyte Colony Stimulating Factor (G-CSF) | ||||
| (j) Sh. Subhash Chand | Therapeutic Monoclonal Antibody Products- | |||
| (i)Rituximab | ||||
| (ii)Trastuzumab | ||||
| (k) Sh. Jaipal Meena | Vaccine Products - | |||
| (i)Bacillus Calmette-Guerin (BCG) vaccine | ||||
| (ii)Live Attenuated Measles vaccine | ||||
| (iii)Live Attenuated Rubella vaccine | ||||
| (iv)Cell Cultutre Rabies vaccine | ||||
| (v)Oral Polio Vaccine | ||||
| 2 | (a) Dr.J. P.Prasad | (i) Human Albumin; | S.O. 2393 (E) dated 2 September, 2015 | |
| (ii) Human Normal Immunoglobulin (Intramuscular and intravenous); | ||||
| (iii) Human Coagulation Factor VIII; | ||||
| (iv) Human Coagulation Factor IX; | ||||
| (b) Ms. Ajanta Sircar | (i)Glucose Test Strips; and | |||
| (ii)Fully automated analyser based glucose reagents. | ||||
| (c) Ms. Kanchan Ahuja | Blood Grouping Reagent | |||
| 3. | (a) Dr.J. P.Prasad | Blood Grouping Reagents | S.O. 2213 (E) dated 26 September 2019 |
|
.gif){kind=logo}
